EPSA6/RT2/FW/MOH-GF-TB-Kit/PH/01/21
December 8, 2021
Tender Code: EPSA6/RT2/FW/MOH-GF-TB-Kit/PH/01/21
Award Status: Partial Winners List
Award Date: 12/08/2021
Tender Award: Download
Unsuccessful Bidders:
Technical Evaluation Result:
Tender no,:EPSA6/RT2/FW/MOH-GF-TB-Kit/PH/01/21 | ||||||||||||
Item.No. | Description | EPSA Request | Proposed winner | Offered unit(Pack size) | Offered quantity | Currency | Offered Unit price(FOB) | Allocated quantity for 3 years | Payment Term | Delivery Time | Remark | |
Unit | quantity | |||||||||||
1 | RHZE (Rifampicin+ Isoniazide+ pyrazinamide+ Ethambutol) + RH(Rifampicin + Isoniazid) -(150mg+75mg+400mg+275mg) 0f 6×28 + (150mg+75mg) of 12×28 – Table | Kit | 369,440 | Macloed Pharmaceuticals Ltd. | 6×28 12×28 | 369,440 | USD | 26.44 | 221,644 | L/C | April 30/2022 for the first Po and within 90 days after L/C opening date for consecutive orders | Winner price |
Sandoz Pharmaceuticals d.d | Kit | 369,440 | USD | 31.01 | 92,360 | L/C | April 30/2022 for the first Po and within 90 days after L/C opening date for consecutive orders | 2nd least price (FCA) | ||||
LUPIN Pharmaceuticals LTD | Kit | 369,440 | USD | 31.41 | 55,416 | L/C | April 30/2022 for the first Po and within 90 days after L/C opening date for consecutive orders | 3rd least price | ||||